194 REFERENCES Torres-Cabala, C., Bibbo, M., Panizo-Santos, A., Barazi, H., Krutzsch, H., Roberts, D. D. and Merino, M. J. (2006). Proteomic identification <strong>of</strong> new biomarkers and application in thyroid cytology., Acta Cytol 50(5): 518– 528. Tukey, J. (1958). Bias and confidence in not-quite large samples, Annals <strong>of</strong> Ma<strong>the</strong>matical Statistics 29: 614. Tyler, R. (1931). What is statistical significance?, 10(5): 115–142. Veltkamp, R. C. and Hagedoorn, M. (2000). Shape similarity measures, properties and constructions, VISUAL ’00: Proceedings <strong>of</strong> <strong>the</strong> 4th International Conference on Advances in Visual In<strong>for</strong>mation Systems, Springer-Verlag, London, UK, pp. 467–476. Verbeek, J. J., Vlassis, N. and Kröse, B. (2003). Efficient greedy learning <strong>of</strong> gaussian mixture models., Neural Comput 15(2): 469–485. Villanueva, J., Martorella, A. J., Lawlor, K., Philip, J., Fleisher, M., Robbins, R. J. and Tempst, P. (2006). Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age., Mol Cell Proteomics 5(10): 1840–1852. Villanueva, J., Shaffer, D. R., Philip, J., Chaparro, C. A., Erdjument- Bromage, H., Olshen, A. B., Fleisher, M., Lilja, H., Brogi, E., Boyd, J., Sanchez-Carbayo, M., Holland, E. C., Cordon-Cardo, C., Scher, H. I. and Tempst, P. (2006). Differential exoprotease activities confer tumor-specific serum peptidome patterns., J Clin Invest 116(1): 271–284. Vlahou, A., Schellhammer, P. F., Mendrinos, S., Patel, K., Kondylis, F. I., Gong, L., Nasim, S. and Jr, G. L. W. (2001). Development <strong>of</strong> a novel proteomic approach <strong>for</strong> <strong>the</strong> detection <strong>of</strong> transitional cell carcinoma <strong>of</strong> <strong>the</strong> bladder in urine., Am J Pathol 158(4): 1491–1502. Vyssotsky, V. A., Corbat, F. J. and Graham, R. M. (1965). Introduction and overview <strong>of</strong> <strong>the</strong> multics system, Proceedings <strong>of</strong> Fall Joint Computer Conference, Vol. 203 <strong>of</strong> AFIPS Conf. Proc. Wagner, M., Naik, D. and Po<strong>the</strong>n, A. (2003). Protocols <strong>for</strong> disease classification from mass spectrometry data., Proteomics 3(9): 1692–1698. Wang, G., Wu, W., Pisitkun, T., H<strong>of</strong>fert, J., Knepper, M. and Shen, R.- F. (2006). Automated quantification tool <strong>for</strong> high-throughput proteomics using stable isotope labeling and LC-MS, Analytical Chemistry 78(16): 5752–5761. Wang, M. Z., Howard, B., Campa, M. J., Patz, E. F. and Fitzgerald, M. C. (2003). <strong>Analysis</strong> <strong>of</strong> human serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometry., Proteomics 3(9): 1661–1666. Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T., Hill, L., Norton, S., Kumar, P., Anderle, M. and Becker, C. (2003). Quantification <strong>of</strong> proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards, Analytical Chemistry 75(18): 4818–4826.
REFERENCES 195 Washburn, M. P., Wolters, D. and Yates, J. R. (2001). Large-scale analysis <strong>of</strong> <strong>the</strong> yeast proteome by multidimensional protein identification technology., Nat Biotechnol 19(3): 242–247. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R., Williams, K. L. and Humphery-Smith, I. (1995). Progress with gene-product mapping <strong>of</strong> <strong>the</strong> mollicutes: Mycoplasma genitalium., Electrophoresis 16(7): 1090–1094. Wasserman, L. (2006). All <strong>of</strong> Nonparametric Statistics (Springer Texts in Statistics), Springer-Verlag <strong>New</strong> York, Inc., Secaucus, NJ, USA. Wells, J. M. and McLuckey, S. A. (2005). Collision-induced dissociation (cid) <strong>of</strong> peptides and proteins., Methods Enzymol 402: 148–185. WfMC (2007). Workflow management coalition reference model, http:// www.wfmc.org, accessed October 11, 2007. Whisstock, J. C. and Lesk, A. M. (2003). Prediction <strong>of</strong> protein function from protein sequence and structure., Q Rev Biophys 36(3): 307–340. Wilkins, M. R., Pasquali, C., Appel, R. D., Ou, K., Golaz, O., Sanchez, J. C., Yan, J. X., Gooley, A. A., Hughes, G., Humphery-Smith, I., Williams, K. L. and Hochstrasser, D. F. (1996). From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis., Biotechnology (N Y) 14(1): 61–65. Witten, I. H. and Frank, E. (2005). Data Mining: Practical machine learning tools and techniques, 2nd edn, Morgan Kaufmann, San Francisco. Wittmann and Heinzle (1999). <strong>Mass</strong> spectrometry <strong>for</strong> metabolic flux analysis., Biotechnol Bioeng 62(6): 739–750. Wolfson, H. J. and Rigoutsos, I. (1997). Geometric hashing: An overview, IEEE Computational Science & Engineering 4(4): 10–21. xia Guan, H., yang Li, C., shu Li, Y., ling Fan, C., Teng, Y., hong Ouyang, Y., Cong, Q. and ping Teng, W. (2006). [thyroid function and thyroid autoimmunity at <strong>the</strong> late pregnancy: data from 664 pregnant women], Zhonghua Fu Chan Ke Za Zhi 41(8): 529–532. Yang, J. and Honavar, V. G. (1998). Feature subset selection using a genetic algorithm, IEEE Intelligent Systems 13(2): 44–49. Zaletel, K., Krhin, B., Gaberscek, S. and Hojker, S. (2006). Thyroid autoantibody production is influenced by exon 1 and promoter ctla-4 polymorphisms in patients with hashimoto’s thyroiditis., Int J Immunogenet 33(2): 87–91. Zarbock, R., Hendig, D., Szliska, C., Kleesiek, K. and Gtting, C. (2007). Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors <strong>for</strong> early disease onset., Clin Chem 53(10): 1734–1740. Zeng, M., Li, J. and Peng, Z. (2006). The design <strong>of</strong> top-hat morphological filter and application to infrared target detection, Infrared Physics and Technology 48: 67–76.
- Page 1 and 2:
New Statistical Algorithms for the
- Page 3 and 4:
Contents Acknowledgments . . . . .
- Page 5 and 6:
New Statistical Algorithms for the
- Page 7 and 8:
Extended Abstract English Version M
- Page 9 and 10:
German Version Das Gebiet der Prote
- Page 11 and 12:
Chapter 1 Introduction and Survey 1
- Page 13 and 14:
1.2. GOALS, OBJECTIVES AND TASKS 7
- Page 15 and 16:
1.2. GOALS, OBJECTIVES AND TASKS 9
- Page 17 and 18:
Chapter 2 Preliminaries 2.1 Topic O
- Page 19 and 20:
2.1. TOPIC OVERVIEW 13 Figure 2.1.1
- Page 21 and 22:
2.1. TOPIC OVERVIEW 15 completeness
- Page 23 and 24:
2.2. AN EXAMPLE 17 (a) Opera A (b)
- Page 25 and 26:
2.2. AN EXAMPLE 19 Figure 2.2.6: Tw
- Page 27 and 28:
2.2. AN EXAMPLE 21 successes. We ca
- Page 29 and 30:
Chapter 3 Mathematical Modeling and
- Page 31 and 32:
3.2. INTRODUCTION TO MALDI TOF MS 2
- Page 33 and 34:
3.2. INTRODUCTION TO MALDI TOF MS 2
- Page 35 and 36:
3.2. INTRODUCTION TO MALDI TOF MS 2
- Page 37 and 38:
3.3. PREPROCESSING 31 mix (external
- Page 39 and 40:
3.3. PREPROCESSING 33 Figure 3.3.5:
- Page 41 and 42:
3.3. PREPROCESSING 35 Figure 3.3.7:
- Page 43 and 44:
3.4. HIGHLY SENSITIVE PEAK DETECTIO
- Page 45 and 46:
3.4. HIGHLY SENSITIVE PEAK DETECTIO
- Page 47 and 48:
3.4. HIGHLY SENSITIVE PEAK DETECTIO
- Page 49 and 50:
3.5. PEAK DETECTION IN 2D MAPS 43
- Page 51 and 52:
3.6. PEAK REGISTRATION (ALIGNMENT)
- Page 53 and 54:
3.6. PEAK REGISTRATION (ALIGNMENT)
- Page 55 and 56:
3.6. PEAK REGISTRATION (ALIGNMENT)
- Page 57 and 58:
3.7. IDENTIFYING POTENTIAL FEATURES
- Page 59 and 60:
3.7. IDENTIFYING POTENTIAL FEATURES
- Page 61 and 62:
3.7. IDENTIFYING POTENTIAL FEATURES
- Page 63 and 64:
3.8. EXTRACTING FINGERPRINTS 57 Fig
- Page 65 and 66:
3.8. EXTRACTING FINGERPRINTS 59 FID
- Page 67 and 68:
3.8. EXTRACTING FINGERPRINTS 61 Dim
- Page 69 and 70:
3.9. COMPLEXITY ANALYSIS 63 3.9 Com
- Page 71 and 72:
Chapter 4 (Bio-)Medical Application
- Page 73 and 74:
4.1. DATA USED 67 4.1.2 Serum Data
- Page 75 and 76:
4.2. STATISTICAL REMARKS 69 1. Vali
- Page 77 and 78:
4.2. STATISTICAL REMARKS 71 Molar v
- Page 79 and 80:
4.2. STATISTICAL REMARKS 73 � Fir
- Page 81 and 82:
4.2. STATISTICAL REMARKS 75 Let ˆ
- Page 83 and 84:
4.2. STATISTICAL REMARKS 77 the boo
- Page 85 and 86:
4.3. STUDY RESULTS 79 Figure 4.3.3:
- Page 87 and 88:
4.3. STUDY RESULTS 81 Figure 4.3.4:
- Page 89 and 90:
4.3. STUDY RESULTS 83 � kNN (gen.
- Page 91 and 92:
4.3. STUDY RESULTS 85 d(x, θi) =
- Page 93 and 94:
4.3. STUDY RESULTS 87 pairs of obje
- Page 95 and 96:
4.3. STUDY RESULTS 89 � “Peptid
- Page 97 and 98:
4.4. IDENTIFICATION OF PROTEOMIC FI
- Page 99 and 100:
4.4. IDENTIFICATION OF PROTEOMIC FI
- Page 101 and 102:
4.4. IDENTIFICATION OF PROTEOMIC FI
- Page 103 and 104:
4.5. IDENTIFICATION OF PROTEOMIC FI
- Page 105 and 106:
4.5. IDENTIFICATION OF PROTEOMIC FI
- Page 107 and 108:
4.6. BIOLOGICAL APPLICATIONS 101 4.
- Page 109 and 110:
Chapter 5 Computer Science Grid Str
- Page 111 and 112:
5.1. INTRODUCTION 105 � A node is
- Page 113 and 114:
5.1. INTRODUCTION 107 of and config
- Page 115 and 116:
5.1. INTRODUCTION 109 particular pr
- Page 117 and 118:
5.2. THE QUASI AD-HOC (QAD) GRID 11
- Page 119 and 120:
5.2. THE QUASI AD-HOC (QAD) GRID 11
- Page 121 and 122:
5.3. QAD GRID PLATFORM SERVER 115 F
- Page 123 and 124:
5.3. QAD GRID PLATFORM SERVER 117 j
- Page 125 and 126:
5.3. QAD GRID PLATFORM SERVER 119 (
- Page 127 and 128:
5.3. QAD GRID PLATFORM SERVER 121 p
- Page 129 and 130:
5.3. QAD GRID PLATFORM SERVER 123 D
- Page 131 and 132:
5.3. QAD GRID PLATFORM SERVER 125 F
- Page 133 and 134:
5.3. QAD GRID PLATFORM SERVER 127 t
- Page 135 and 136:
5.4. QAD GRID WORKER 129 field. A w
- Page 137 and 138:
5.4. QAD GRID WORKER 131 2. This re
- Page 139 and 140:
5.4. QAD GRID WORKER 133 Figure 5.4
- Page 141 and 142:
5.4. QAD GRID WORKER 135 Checkpoint
- Page 143 and 144:
5.4. QAD GRID WORKER 137 database b
- Page 145 and 146:
5.5. QAD GRID PLATFORM SERVICES 139
- Page 147 and 148:
5.6. QAD GRID WORKFLOWS 141 � Dat
- Page 149 and 150: 5.6. QAD GRID WORKFLOWS 143 Service
- Page 151 and 152: 5.6. QAD GRID WORKFLOWS 145 Figure
- Page 153 and 154: 5.7. RELATED WORK 147 to set-up sys
- Page 155 and 156: 5.7. RELATED WORK 149 Table 5.7.1 -
- Page 157 and 158: Chapter 6 proteomics.net - Product-
- Page 159 and 160: 6.2. CASE STUDIES 153 6.2 Case Stud
- Page 161 and 162: 6.2. CASE STUDIES 155 Figure 6.2.2:
- Page 163 and 164: 6.2. CASE STUDIES 157 MASCOT and SE
- Page 165 and 166: 6.2. CASE STUDIES 159 The peak pick
- Page 167 and 168: 6.2. CASE STUDIES 161 first entry i
- Page 169 and 170: 6.2. CASE STUDIES 163 Approach Base
- Page 171 and 172: 6.2. CASE STUDIES 165 Figure 6.2.5:
- Page 173 and 174: Chapter 7 Related Work In this chap
- Page 175 and 176: Chapter 8 Conclusion and Future Dir
- Page 177 and 178: 8.3. FROM BIOMARKERS TO BIOPRINTS 1
- Page 179 and 180: Appendix A Implementation Details T
- Page 181 and 182: Appendix B Curriculum Vitae Name Ti
- Page 183 and 184: References Aebersold, R. and Mann,
- Page 185 and 186: REFERENCES 179 Breiman, L. (2001).
- Page 187 and 188: REFERENCES 181 Downard, K. M. and M
- Page 189 and 190: REFERENCES 183 Gillette, M. A., Man
- Page 191 and 192: REFERENCES 185 Huyghe, E., Muller,
- Page 193 and 194: REFERENCES 187 Kuijpens, J. L. P.,
- Page 195 and 196: REFERENCES 189 McLachlan, S. M. and
- Page 197 and 198: REFERENCES 191 Platt, J. C. (1999).
- Page 199: REFERENCES 193 Stone, M. (1974). Cr